Abstract
Gene therapy has been receiving widespread attention due to its unique advantage in regulating the expression of specific target genes. In the field of cancer gene therapy, modulation of gene expression has been shown to decrease oncogenic factors in cancer cells or increase immune responses against cancer. Due to the macromolecular size and highly negative physicochemical features of plasmid DNA, efficient delivery systems are an essential ingredient for successful gene therapy. To date, a variety of nanostructures and materials have been studied as nonviral gene delivery systems. In this review, we will cover nonviral delivery strategies for cancer gene therapy, with a focus on target cancer genes and delivery materials. Moreover, we will address current challenges and perspectives for nonviral delivery-based cancer gene therapeutics.
Keywords: Cancer gene therapy, Nonviral gene therapy, Nonviral delivery, Target cancer gene, Macromolecular, DNA.
Current Gene Therapy
Title:Nonviral Delivery Systems for Cancer Gene Therapy: Strategies and Challenges
Volume: 18 Issue: 1
Author(s): Gayong Shim*, Dongyoon Kim, Quoc-Viet Le, Gyu Thae Park, Taekhyun Kwon and Yu-Kyoung Oh*
Affiliation:
- College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826,Korea
- College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826,Korea
Keywords: Cancer gene therapy, Nonviral gene therapy, Nonviral delivery, Target cancer gene, Macromolecular, DNA.
Abstract: Gene therapy has been receiving widespread attention due to its unique advantage in regulating the expression of specific target genes. In the field of cancer gene therapy, modulation of gene expression has been shown to decrease oncogenic factors in cancer cells or increase immune responses against cancer. Due to the macromolecular size and highly negative physicochemical features of plasmid DNA, efficient delivery systems are an essential ingredient for successful gene therapy. To date, a variety of nanostructures and materials have been studied as nonviral gene delivery systems. In this review, we will cover nonviral delivery strategies for cancer gene therapy, with a focus on target cancer genes and delivery materials. Moreover, we will address current challenges and perspectives for nonviral delivery-based cancer gene therapeutics.
Export Options
About this article
Cite this article as:
Shim Gayong *, Kim Dongyoon , Le Quoc-Viet, Park Thae Gyu, Kwon Taekhyun and Oh Yu-Kyoung*, Nonviral Delivery Systems for Cancer Gene Therapy: Strategies and Challenges, Current Gene Therapy 2018; 18 (1) . https://dx.doi.org/10.2174/1566523218666180119121949
DOI https://dx.doi.org/10.2174/1566523218666180119121949 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Aerosol Delivery in the Treatment of Lung Cancer
Current Cancer Drug Targets Imidazole/Cyanuric Acid as an Efficient Catalyst for the Synthesis of 2-Amino-4H-chromenes in Aqueous Media at Ambient Temperature
Letters in Organic Chemistry Using Cheminformatics for the Identification of Biological Functions of Small Molecules in Metabolic Pathway
Current Topics in Medicinal Chemistry Advances in In-Silico based Predictive In-Vivo Profiling of Novel Potent β-Glucuronidase Inhibitors
Current Cancer Drug Targets Cytokines as Anti-Angiogenic Agents in Haematological Malignancies
Current Cancer Drug Targets Combining Drug-Loaded Nanobubbles and Extracorporeal Shock Waves for Difficult-to-Treat Cancers
Current Drug Delivery Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Editorial (Thematic Issue: Therapy at the Nano Dimension)
Current Pharmaceutical Design Investigation of Fucoidan-Oleic Acid Conjugate for Delivery of Curcumin and Paclitaxel
Anti-Cancer Agents in Medicinal Chemistry Current Treatments of Primary Sclerosing Cholangitis
Current Medicinal Chemistry RNA Base Damage and Repair
Current Pharmaceutical Biotechnology Cellulose-based Nanocarriers as Platforms for Cancer Therapy
Current Pharmaceutical Design A Novel Recombinant Multi-Epitope Vaccine Could Induce Specific Cytotoxic T Lymphocyte Response <i>In Vitro</i> and <i>In Vivo</i>
Protein & Peptide Letters Development of a Novel Human scFv Against EGFR L2 Domain by Phage Display Technology
Current Pharmaceutical Design Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer
Current Pharmaceutical Design Optimizing Gene Silencing Strategies for Pancreatic Cancer
Current Cancer Therapy Reviews Exploiting Cancer Metal Metabolism using Anti-Cancer Metal- Binding Agents
Current Medicinal Chemistry PPAR- γ Agonist in Treatment of Diabetes: Cardiovascular Safety Considerations
Cardiovascular & Hematological Agents in Medicinal Chemistry Pyrrolocarbazoles as Checkpoint 1 Kinase Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Contributions of the Interaction Between Dietary Protein and Gut Microbiota to Intestinal Health
Current Protein & Peptide Science